Merck KGaA’s Oncology Sales And Pipeline Updates Dominate Q3 Earnings

Bavencio Sees Double-Digit Growth

The German firm’s oncology franchise grew to more than €400m in the third quarter as sales of Bavencio doubled, while anticancer partnerships and pipeline updates drew interest.      

The winter ends and the springtime shows fresh green and snow covered flowers after snowfall with melting ice and melting snow in the spring sunshine to welcome the revival of life
Merck Is Reviving Its Oncology Pipeline Through Collaboration Deals • Source: Shutterstock

More from Earnings

More from Business